1.A Case of Recurrent Annular Erythema of Sjogren's Syndrome Treated with Hydroxychloroquine.
Ji Hye LEE ; Jong Hoon KIM ; Jae Yong SUNG ; Seung Hun LEE
Korean Journal of Dermatology 2014;52(1):64-66
No abstract available.
Erythema*
;
Hydroxychloroquine*
;
Sjogren's Syndrome*
2.A Case of Lung Involvement Showing Multiple Lung Cysts in Primary Sjogren's Syndrome.
Ji Yon KIM ; Hyun Gyu HWANG ; Jae Sung CHOI ; Ki Hyun SEO ; Yong Hoon KIM ; Mee Hye OH ; Ju Ock NA
Tuberculosis and Respiratory Diseases 2008;64(3):230-235
No abstract available.
Lung
;
Lymphocytes
;
Sjogren's Syndrome
3.Pulmonary Nodular Amyloidosis in a Patient with Sjogren Syndrome.
Yeonmi JU ; Won Seok LEE ; Wan Hee YOO
Journal of Rheumatic Diseases 2014;21(3):170-171
No abstract available.
Amyloidosis*
;
Humans
;
Sjogren's Syndrome*
4.Extraglandular Manifestations of Korean Patients with Primary Sjogren's Syndrome.
Journal of Rheumatic Diseases 2015;22(4):211-212
No abstract available.
Humans
;
Sjogren's Syndrome*
5.Probing into Second Pathological Factors of Sjögren's Syndrome.
Cheng-yin LI ; Ting-ting YAN ; Su-ling WU ; Wang YUE
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(6):752-754
Sjögren's syndrome is a chronic autoimmune disease with unclear etiology. From the point of etiology, Chinese medicine (CM) theory holds that pathological products like dry toxin, blood stasis are produced in the pathological process. They are both pathologic results and pathogenic factors for its further development. So pathological products are also named as second pathogenic factors. In this article, the concept of second pathogenic factors was sorted and defined. Main second pathogenic factors of Sjögren's syndrome were pinpointed, and their modern medical bases were analyzed. Authors came to a conclusion that clearing away second pathogenic factors is a key point in treating Sjögren's syndrome.
Humans
;
Sjogren's Syndrome
;
pathology
6.Cerebral Large-Vessel Vasculitis in Sjogren's Syndrome: Utility of High-Resolution Magnetic Resonance Vessel Wall Imaging.
Gopikrishnan UNNIKRISHNAN ; Nikhil HIREMATH ; Kesavadas CHANDRASEKHARAN ; Sapna E SREEDHARAN ; Padmavathy Narayanan SYLAJA
Journal of Clinical Neurology 2018;14(4):588-590
No abstract available.
Sjogren's Syndrome*
;
Vasculitis*
7.Successful treatment of sensorineural hearing loss in Sjögren's syndrome with corticosteroid.
The Korean Journal of Internal Medicine 2016;31(3):612-615
No abstract available.
Hearing Loss, Sensorineural*
;
Sjogren's Syndrome
8.Benign Lymphoepithelial Lesion of Parotid Gland and Secondary Amyloidosis as Concurrent Manifestations in Sjogren's Syndrome.
Hii Sun JEONG ; Hye Kyung LEE ; You Jung HA ; Dae Hyun KIM ; In Suck SUH
Archives of Plastic Surgery 2015;42(3):380-383
No abstract available.
Amyloidosis*
;
Parotid Gland*
;
Sjogren's Syndrome*
9.A case of Sjogren's syndrome with interstitial pneumonitis.
Jun Young PARK ; Kyu Rak YI ; Sang Moo LEE ; Hyeon Tae KIM ; Soo Taek UH ; Yeontae CHUNG ; Yong Hun KIM ; Choon Sik PARK ; So Young JIN
Tuberculosis and Respiratory Diseases 1992;39(4):348-354
No abstract available.
Lung Diseases, Interstitial*
;
Sjogren's Syndrome*
10.Indexes used to evaluate the disease activity of Sjögren's syndrome.
Zhijun WANG ; Chuangqi YU ; Lingyan ZHENG@
West China Journal of Stomatology 2013;31(5):541-544
Sjögren's syndrome (SS) is a systemic autoimmune disease that mainly affects the exocrine glands. A set of indexes have been established to evaluate the disease activity in SS, including symptoms, systemic characteristics, and long-term disease damage as well as the patients' quality of life. This article briefly introduced the background, content, and scoring rules of SS indexes. Current clinical applications and prospects were also reviewed.
Humans
;
Quality of Life
;
Sjogren's Syndrome
Result Analysis
Print
Save
E-mail